{"database": "openregs", "table": "documents", "rows": [["FDA-2017-D-6580-5125", "FDA", "FDA-2017-D-6580", "Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry; Extension of Comment Period", "Notice", "Extension of Comment Period", "2020-01-08T05:00:00Z", 2020, 1, "2020-01-08T05:00:00Z", null, "2020-01-08T14:54:20Z", "2020-00091", 0, 0, "090000648427bef7"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2017-D-6580-5125"], "units": {}, "query_ms": 107.3224910069257, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}